Idelalisib works against leukemia, trial stopped early Curetoday.com (press release) The phase 3 trial compared treatment with idelalisib and another drug, Rituxan (rituximab), to treatment with Rituxan alone in patients with CLL who were not eligible for treatment with chemotherapy. Gilead said an interim analysis by the data ... |
